Kolexia
Adhoute Xavier Gastro-entérologie
Adhoute Xavier
Gastro-entérologie
Cabinet libéral
Marseille, France
102 Activités
39 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Hépatite Hépatite C Fibrose Adénocarcinome Hépatite C chronique Cirrhose du foie

Collaborateurs

Voir plus
Bourliere Marc
Bourliere Marc
Hopital Saint Joseph, Marseille, France
Castellani Paul
Castellani Paul
Hôpital La Casamance, Aubagne, France
Perrier Herve
Perrier Herve
Cabinet libéral, Marseille, France
Raoul Jean-Luc
Raoul Jean-Luc
Institut de cancérologie de l'Ouest, Saint-Herblain, France

Industries

Voir plus
Ipsen
19 collaboration(s)
Dernière en 2022
Bayer
10 collaboration(s)
Dernière en 2023
Servier
7 collaboration(s)
Dernière en 2023
A+A
6 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
HESTIA: A Multicentric National Phase II Trial Assessing TIslelizumab in Monotherapy for Patients With Hepatocellular Carcinoma Child-Pugh B and ALBI Grade 1 or 2 Liver Function Score
Essai Clinique (Unicancer)   06 novembre 2023
Surgical treatment of tertiary hyperparathyroidism: does one fit for all?
Frontiers in endocrinology   02 novembre 2023
AB-LATE02: Neoadjuvant Atezolizumab and Adjuvant Atezolizumab + Bevacizumab in Combination With Percutaneous Radiofrequency Ablation of Small HCC: a Multicenter Randomized Phase II Trial
Essai Clinique (CHU Montpellier)   01 août 2023
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis.
Journal of clinical and translational hepatology   16 mai 2023
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Cancers   06 avril 2023
Radiomics, a Promising New Discipline: Example of Hepatocellular Carcinoma.
Diagnostics (Basel, Switzerland)   30 mars 2023
Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective.
Targeted oncology   06 février 2023
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching.
World journal of gastrointestinal oncology   28 septembre 2022
Response to immunotherapy plus anti-angiogenic agent combination challenges hepatocellular carcinoma prognostic scores.
Hepatology communications   12 juillet 2022
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results.
World journal of clinical cases   31 juillet 2021